Rubicon Research’s 60x FY25 earnings tag is igniting debates as 2025’s IPO wave gathers steam. At the same time, LG Electronics’ listing run is fueling optimism about listing gains. [1][2]
High price vs. US moat — Rubicon’s price tag is steep: 60x FY25 earnings, with 98.5% of revenue from the US and top five customers making up 77% of sales. The plan to deploy IPO proceeds to pay off ₹310 crore of debt adds balance-sheet clarity but concentrates risk. [1]
Rubicon’s growth narrative — The pharma play has surged from ₹4,190 crore in FY23 to ₹12,962 crore in FY25, posting net profit of ₹1,344 crore and EBITDA margins at 21%. The Validus Pharmaceuticals acquisition expands its US specialty-drug footprint, strengthening the growth thesis. [3][3]
Bubble chatter — A subset of investors flags an IPO bubble, weighing Rubicon’s US-focused moat against the lofty multiple and the need for execution to justify the price. [3]
LG vs Tata Capital on the altar of deal-flow — LG Electronics’ IPO is largely an OFS, while Tata Capital’s issue is rumored around 40-50% fresh. Proceeds dynamics matter: LG’s funds aren’t going to promoters, and deal-flow remains a live debate. [4]
LG’s listing gains and retail cadence — The final listing stats point to solid gains; subscription moved from around 2:1 to over 3:1, sparking chatter about who gets allocations. [2]
Lenskart nod signals more to come — Lenskart Solutions gets SEBI’s nod to float, underscoring ongoing deal-flow in 2025. [5]
Closing thought: In 2025, retail allocations and market sentiment will keep shaping which IPOs win or lose. [3]
References
Discusses Rubicon Research IPO price at 60x, US exposure risk, debt payoff, and mixed views on valuation and risk overall.
View sourceLG IPO final stats
LG IPO final stats, high listing gains, subscription demand, retail vs. HNI allocation, and allotment questions noted.
View sourceRubicon Research IPO Analysis. Is it worth your Investment?
Rubicon Research IPO analysis; strong US pharma footprint; comments skeptical on IPO bubble; bullish on Rubicon, cautious on market overall.
View sourceTata Capital IPO vs LG Electronics IPO
Compares Tata Capital IPO with LG Electronics IPO; discusses fresh vs OFS, GMP, and potential performance trends for investors here
View sourceLenskart Solutions gets SEBI’s nod to float IPO
Lenskart Solutions gains SEBI approval to float an IPO; discussion notes profitability and anticipation.
View source